In addition to reduced SATB2 protein immunoreactivity, we also observed decreased SATB2 transcript content in tumor tissues, which is in line with the findings of other authors [22,24] and advocates a tumor suppressor role for SATB2. The gene discussed is SATB2; the disease is neoplasm.